Mutations of the survival motor neuron gene SMN1 cause the inherited disease spinal muscular atrophy. The ubiquitous SMN protein facilitates the biogenesis of spliceosomal small nuclear ribonucleoproteins, snRNPs. The protein is detected in the cytoplasm, nucleoplasm and enriched with snRNPs in nuclear Cajal bodies. It is structurally divided at least into an amino-terminal region rich in basic amino acid residues, a central Tudor domain, a self-association tyrosine/glycine-box and an exon7-encoded carboxy-terminus. To examine the domains required for the intranuclear localization of SMN, we have used fluorescently 
Introduction
Proximal spinal muscular atrophy (SMA) is a group of autosomal recessive neuromuscular disorders with childhood onset characterized by motor neuron degeneration and progressive paralysis. The disease is caused by mutations of the gene encoding the survival motor neuron (SMN) protein, SMN1 (Lefebvre et al., 1995) . SMN1 and its nearly identical copy, SMN2, are within duplications on chromosome 5q13. Compared to SMN1, SMN2 is unique in that a single nucleotide change generates alternative splicing of SMN2 exon 7 (ex7), resulting in replacement of the C-terminal 16 amino acids (aa) by a 4-aa sequence (SMNDex7). Indeed, it has been demonstrated that this unique nucleotide is included in a splice enhancer (Hofmann et al., 2000; Cartegni et al., 2002) and/or a splice inhibitor site (Kashima and Manley, 2003) . The identical full-length SMN1 and SMN2
transcripts produce the ubiquitous 38 kDa SMN protein (Liu and Dreyfuss, 1996; Coovert et al., 1997; Lefebvre et al., 1997) . A close correlation exists between the reduced levels of the SMN protein and the severity of SMA disease (Coovert et al., 1997; Lefebvre et al., 1997) .
The level of SMN fluctuates considerably in different cell types and during development (Burlet et al., 1998; La Bella et al., 1998) . This modulation appears to be a key to its function, since the integrity of nuclear bodies (NBs) could be disrupted after SMN depletion in SMA patients and mouse models (Schrank et al., 1997; Frugier et al., 2000; Hsieh-Li et al., 2000; DiDonato et al., 2001; Monani et al., 2003) . Why SMN and SMNDex7 isoforms exist remains unknown. It is recognized that they have different functional properties, such that SMNDex7, which preponderates in SMA patients, does not fully compensate for the absence of SMN1 (Lefebvre et al., 1995) . The mechanism by which SMN depletion induces the neuromuscular defect is still elusive.
The SMN protein localizes mostly in the cytoplasm and accumulates in nuclear bodies frequently overlapping with Cajal bodies (CBs), named gems (gemini of CBs; Liu and Dreyfuss, 1996) . SMN is a component of a large multiprotein complex comprising gemin2 to 7, which participates in the assembly of proteins and RNAs (reviewed in Meister et al., 2002a; Gubitz et al., 2004) . Particularly, it has been shown that SMN facilitates various steps of the biogenesis of the spliceosomal U snRNPs (Uridine-rich small nuclear ribonucleoproteins) that are part of the spliceosome essential for the removal of introns during pre-mRNA splicing.
The biogenesis of snRNPs (U1, U2, U4 and U5) constitutes a complex pathway occurring in both the cytoplasm and nucleus (Will and Luhrmann, 2001 ). The SMN complex facilitates cytoplasmic assembly of spliceosomal Sm core proteins onto U snRNAs and recruitment of the snRNA cap hypermethylase (TGS1; Mouaikel et al., 2003) , leading to the formation of nuclear import-competent snRNPs. The SMN complex remains associated with the snRNPs along the entire cytoplasmic pathway (Massenet et al., 2002) . In the nucleus, it appears that the CB-containing the SMN complex are the first sites of accumulation of newly imported snRNPs (Carvalho et al., 1999 , Sleeman et al., 2001 and are involved in early nuclear stages of snRNA maturation (Jàdy et al., 2003) .
SMN is encoded by eight exons generating a multidomain polypeptide of 294 aa (see Fig.2A ). It contains the central Tudor domain flanked by a N-terminal lysine (K)-rich sequence and in the C-terminal region, by a proline (P)-rich, a tyrosine/glycine (YG)-box and the ex7 encoded domains. The Tudor domain, named because of its structural homology to repeats of the Drosophila tudor protein, is conserved among different RNA-binding proteins (Pontig, 1997; Selenko et al., 2001 ) and mediates SMN interaction with arginine-glycine (RG) motifs in several proteins (reviewed in Meister et al., 2002a; Gubitz et al., 2004) , including the CB marker coilin and the Sm core proteins and their symmetrically dimethylated arginine (sDMA) isoforms (Friesen et al., 2001; Meister and Fischer., 2002b; Hebert et al., 2002; Boisvert et al., 2002) . The K-rich sequence is embedded in the interspecies conserved RNAbinding domain (Lorson and Androphy, 1998a; Bertrandy et al., 1999) . The P-rich domain associates with the actin-binding protein profilin (Giesemann et al., 1999) . The YG-box domain is implicated in self-association in vitro (Lorson et al., 1998b ) and a putative cytoplasmic retention signal is encoded by ex7 (Zhang et al., 2003) .
Unravelling mechanisms by which a protein is localized to various subnuclear compartments is primordial to understand nuclear organization and human diseases (Phair and Misteli, 2000; Carmo-Fonseca et al., 2002; Bubulya and Spector, 2004; Zaidi et al., 2004) .
Thus far, no clear overview of the role of the SMN domains, particularly of the Tudor domain, in subnuclear localization exists (Mohaghegh et al., 1999; . The overexpressed SMA mutant SMN472D5 lacking the C-terminal half of SMN is localized throughout the nucleus (Lefebvre et al., 2002) . Why SMN472D5 presents such a distribution has awaited further investigations. Here, we have systematically analysed the functional SMN domains and showed that they govern nucleocytoplasmic partition and intranuclear localization in the nucleoplasm, nucleoli and gems/CBs. The central Tudor domain cooperates with the YG-box and the K-rich sequence for the accumulation of SMN in CBs. The U snRNPs fail to concentrate in CBs of cells transiently transfected with the SMA mutant SMNDex7, suggesting a role of the ex7 domain for the localization of U snRNPs in CBs.
Furthermore, in fibroblasts of SMA patients there is no accumulation of snRNPs in NBs, indicating that SMN depletion affects the spatio-temporal distribution of snRNPs.
Materials and Methods

Engineered fluorescently tagged proteins
Full-length and SMN mutants were prepared by PCR-amplification from full-length human cDNA (Lefebvre et al., 1995) , digested and subcloned into the appropriate restriction sites of the pEGFP vectors (Clontech). Subcloning the RT-PCR fragment from total RNA preparation of an SMA patient produced SMNDex7. Mutations were introduced in the GFP recombinants using the QuickChange mutagenesis kit (Stratagene). Oligonucleotides used for mutagenesis are available upon request. DNA sequencing and FP-immunoblotting confirmed the constructs.
Cell cultures and transfections COS7, HeLa and human fibroblast cultures were maintained in DMEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml). Cells were plated in a 8-chamber culture Slide (Becton Dickson Lab.) and transfected with purified plasmid using FuGENE 6 (Roche Diagnostics) as described previously (Lefebvre et al., 2002) .
Immunofluorescence and microscopy
At 16-48h post-transfection, COS and human cells were prepared for fluorescence microscopy (Lefebvre et al., 1997) . The following antibodies were used: anti-TMG (mouse mAb at 1:4000, Calbiochem), anti-U2 snRNP-specific protein U2B" (4G3 mouse mAb at 1:200, ICN Pharmaceuticals), anti-coilin (mouse mAb at 1:125, Abcam or a kind gift from M.
Carmo-Fonseca), anti-SMN (mouse mAb at 1:500, Trans Lab or 4B3 at 1:500, Burlet et al., 1998) , purified rabbit anti-SMN peptide (1:500), secondary anti-rabbit and anti-mouse Cy3
(1:500, Jackson Laboratories) and anti-mouse Alexa 488 (1:500, Molecular Probes). Samples were incubated with 4,6-diamidino-2-phenylindole (DAPI, 0.1 mg/ml), mounted in either AF1
(Cityfluor) or Mowiol (Hoechst) and observed by nonconfocal (Leica DMR, objective 63x/1,32) or confocal (LEICA TCS SP2 AOBS, objective 63x/1,32) microscopy.
Nonconfocal images acquired with a cooled CCD camera (Micromax, Princetown Instruments, Inc.) using MetaView Imaging System were processed by ImageJ (rsb.info.nih.gov/ij) and prepared using Adobe photoshop.
Analysis of the fluorescence signals
Fluorescence images were acquired as a series (stack) of optical sections of 1 mm along the optical axis (z) of the entire cell using a on a confocal microscope (LEICA TCS SP2 AOBS).
The sensitivity of the photomultiplier tube was adjusted so that the fluorescence signal of the FP-fusion proteins was below the saturation level. The monographies (512x512 pixels) of each optical section were captured as 8-bit grayscale images. A segmentation algorithm was used to define the 'objects' by applying a threshold to each of the z-sections (ImageJ). The same segmentation algorithm was applied to automatically define the nuclear region by DAPI staining of each z-section. The proportion of fluorescence within the nucleus was calculated using ImageJ and was expressed as the percentage of the total fluorescence contained in the entire stack of z-sections. Ten cells were randomly selected and examined for each construct.
The results presented values obtained from independent experiments and the significance was determined using the non-parametric Mann-Whitney test.
Flow cytometry
Cell sorting was performed with an EPICS Elite -ESP flow cytometer (Beckman-Coulter) equipped with a 15 mw argon-ion laser emitting at 488 nm and collecting through a 520 + 15 nm bandpass filter for eGFP measurements. Sort windows were set to include cells with correct scatter profile and positive eGFP fluorescence.
Co-immunoprecipitations
The anti-GFP (Clonetech), anti-TMG (Calbiochem) and normal antibodies (DAKO) were incubated overnight at 4°C with total protein lysates from transfected cells with RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP40, 0.1% SDS) in presence of RNAsin (1 U/ml, Promega) and protease inhibitors, and bound to Dynabeads M-280 sheep anti-rabbit or anti-mouse IgG (Dynal) for 2 hr at 4°C (Lefebvre et al., 2002) . After four washes in RIPA, the proteins were eluted in SDS loading sample buffer and resolved by SDS-PAGE.
Immunoblot analyses
The proteins resolved by SDS-PAGE were transferred to a PVDF membrane and incubated with antibodies directed against GFP (mouse mAb at 1:1000, Roche Diagnostics), SMN (mouse mAb at 1:1000, Transduction Laboratories), gemin2 (mouse mAb at 1:1000, Abcam), Sm proteins (Y12 mouse mAb at 1:500, Abcam) and a-tubulin (mouse mAb at 1:10000, Sigma). The membranes were incubated with horseradish peroxidase-conjugated secondary antibody and detected by chemiluminescence (Amersham).
Results
The fluorescently tagged SMN protein behaves like the endogenous SMN
The localization of transiently expressed fluorescently tagged (FP)-SMN in COS cells and immortalized Type I (severe) SMA fibroblasts was compared to the localization of the endogenous SMN (Fig. 1) . Immunofluorescence microscopy showed that SMN localized in the cytoplasm and concentrated in NBs in COS cells as reported in HeLa cells (Fig. 1A, Liu and Dreyfuss, 1996) . In immortalized Type I SMA fibroblasts containing residual levels of SMN (Lefebvre et al., 2002) , SMN was detected in the cytoplasm, nucleoplasm and occasionally, in NBs (Fig. 1D ). Each cell line was transfected with FP-SMN and the distribution of transfected and endogenous SMN was similar (Fig. 1B, E 
The Tudor domain is not sufficient for SMN localization in CBs
The RG-motif of coilin serves to recruit the SMN to CBs (Hebert et al., 2002) , but the SMN Tudor domain interacts with the RG-motif of other proteins (reviewed in Terns and Terns, 2001; Meister et al., 2002a; Gubitz et al., 2004) , and it seemed likely that localization in CBs might involve other regions of SMN. To test this hypothesis, we generated ( Fig. 2A) and transiently overexpressed a series of fluorescently tagged SMN deletion mutants in COS cells. We chose the primate COS cells that do not have the SMN2 gene and consequently, do not express the SMNDex7 transcript. The integrity of fusion proteins was first verified by immunoblotting analyses (Fig. 2B) . Each construct expressed a protein at the expected position. Given the transfection efficiency, the levels of fusion proteins were comparable, except for ex2B, as judged by both anti-tubulin and anti-SMN incubations.
Protein localization in transfected COS cells was analysed by fluorescence microscopy ( Fig. 2C ). SMN protein was first divided into three fragments containing the N-terminal region FP-SMNN86 (aa 1-86, N86), the central Tudor domain FP-SMNTudor (aa 87-146, Tudor) or the C-terminal region FP-SMNDN189 (aa 190-294, DN189). All these failed to accumulate in nuclear foci, demonstrating that none of these regions alone contains sufficient information for targeting to NBs. Fragments N86 and Tudor accumulated in respectively nucleoli and irregularly shaped nuclear substructures resembling speckles, and DN189 was localized in the cytoplasm. These results indicated that the sequences necessary for localization in NBs encompassed more than one region covered by the deletions.
It was first possible to conclude that a combination of N86 and the Tudor domain contributed to the localization of the SMA mutant SMN472D5 (aa 1-146, 472D5) in NBs.
This mutant also localizes in the nucleoplasm and nucleoli ( Fig. 2C ; Lefebvre et al., 2002) .
Previous studies have implicated protein self-association in the formation of NBs (Hebert et al., 2000) . A self-association domain has been mapped to the region encoded by SMN exon2B
(aa 52-91; Young et al., 2000) . To explore the role of this domain in localization, the construct FP-SMNex2B (aa 52-86) was generated and overexpressed: no fluorescence signal was observed in NBs, the protein being nuclear and concentrated in nucleoli, as judged by DAPI staining (Supplemental Fig. S1 ). We performed further mutagenesis experiments to identify which residues of the N-terminal region were responsible for the accumulation of To further address the role of self-association in the localization of SMN, we tested deletions of the C-terminal ex7 and YG-box regions, which are involved in self-association of SMN (Lorson et al., 1998a) . FP-SMNDex7 (consisting of aa 1-278 plus the first 4 aa from ex8, Dex7) localized in the cytoplasm, nucleoplasm and nuclear foci (Mohaghegh et al., 1999; . Additional deletion of the YG-box in FP-SMNDC40 (aa 1-254, DC40)
showed a diffuse cytoplasm with a few aggregates (Fig. 2C ). The simplest interpretation for these aggregates would be that they are due to proline stretches at the C-terminus of the protein. In the nucleus, DC40 was detected exclusively in the nucleoplasm, as were SMNDex6/7 (aa 1-278; Vyas et al., 2002) and FP-SMNN194 (aa 1-194, N194, Fig. 2C ).
These results suggest that proline stretches move N194 away from NBs when compared with 472D5 and that the self-association YG-box enhances the localization of SMN to NBs. To test this possibility, we generated FP-SMNDN86 (aa 87-294, DN86) that corresponds to the addition of the Tudor domain to the C-terminal region DN189. D N86 localized in the cytoplasm and in contrast with DN189, accumulated in NBs, indicating that the Tudor and YG-box domains cooperate to localize in NBs (Fig. 2C ). In addition, DN86 showed large cytoplasmic aggregates (blobs), which were not observed by overexpression of full-length FP-SMN (Fig. 1B) under our experimental conditions. In other studies the FP-SMN was shown to form cytoplasmic aggregates upon high expression levels (Shpargel et al., 2003; Sleeman et al., 2003) . To exclude the possibility that localization in NBs was mediated by endogenous SMN, immortalized type I SMA fibroblasts with almost no NBs (6% of cells) were transfected with SMN constructs (Figs 1E, S2: D ex7, 472D5 and Tudor shown only).
Localization in NBs of SMN mutants appears independent of the levels of endogenous SMN, indicating that transfected proteins present intrinsic properties. Similar localization patterns were also obtained in transfected HeLa cells (Fig. S3 ).
The NBs formed by the SMN mutants in transfected COS cells were further examined by immunofluorescence labelling of CB marker coilin. Coilin-positive CBs were nuclear substructures present in cells expressing the SMN mutants (Fig. 3 , Table 1 ). The nuclear foci in FP-SMN transfected cells showed complete colocalization of FP-SMN and coilin. The SMN mutant Dex7, 472D5 and DN86 also showed complete colocalization with coilin in nuclear foci and they can be considered as CBs. However, the number of coilin foci obtained with these mutants was greater than in FP-SMN transfected cells, which was comparable to the number of foci in untransfected cells (Fig. 1G ). In contrast, the FP signal failed to accumulate in CBs of cells transfected with N86, Tudor, ex2B, DC40 or DN189 (Fig. 3) . Our results indicate that overexpression of SMN deletion mutants does not interfere with the ability of CBs to accumulate coilin.
Multiple interacting motifs regulate the nucleocytoplasmic distribution of SMN
To further characterize the nucleocytoplasmic distribution of FP-fusion proteins, we examined the ratio of fluorescence intensity in the nucleus versus the whole cell by confocal microscopy (Fig. 4A ). The heterogeneity in fluorescence partitioning of some constructs was possibly due to cytoplasmic signals outside the threshold range. The analyses revealed that DN86 and FP-SMN had similar nuclear proportion of fluorescence (Mann-Whitney test, not significant at P£5%), indicating that removal of the N-terminal region has no effect on nucleocytoplasmic partitioning of SMN. The fraction of Dex7 associated with the nucleus was significantly increased compared to FP-SMN (P£5%). The nuclear fraction of DC40 was also increased compared to Dex7 (P£5%). These results indicate that efficient oligomerization mediated by the YG-box and ex7 domain contributes to the nucleocytoplasmic distribution of SMN. Additional removal of aa 147 to 194 encoded by exon 4 caused the increase of 472D5
in the nucleus compared to DC40 and N194 (P£5%). We then tested whether accumulation in CBs might influence the value of the nuclear fraction. 472D5 and 472D5M2 were similarly associated with the nucleus, indicating that CB accumulation was dispensable for nuclear localization. In addition, the nuclear fraction of both the Tudor and ex2B regions increased compared to the other SMN constructs (P£5%). To further assess their importance in nuclear localization of SMN, the ex2B and Tudor regions were independently fused to the cytoplasmic protein 14.3.3g conjugated to eGFP (Strochlic et al., 2004, Fig. 4B-D) : only the Tudor domain contained information to localize the protein in the nucleus. This agrees with the observation that partial deletion of the ex2B region has no major effect on the nucleocytoplasmic distribution of SMN . From these studies we concluded that SMN has no classical NLS and that nuclear accumulation is regulated positively by the Tudor domain and negatively by the C-terminal portion of SMN.
SnRNPs presence is not critical for the localization of SMN mutants in CBs
It has been shown that overexpression of SMNDN27 lacking the first 27 N-terminal aa results in the redistribution of the snRNPs to enlarged cytoplasmic and nuclear structures (Pellizzoni et al., 1998) . To extend these observations, we determined whether our SMN mutants localized in CBs due to the presence of snRNPs (Table 1, Fig. 5 ). The distribution of the TMG-capped snRNA of snRNPs was examined. The speckled nucleoplasmic distribution of TMG in transfected cells appeared similar to that of untransfected cells (Fig. 1I) , indicating no striking effect of the transfected SMN mutants tested over the nucleoplasmic pool of snRNPs (Fig. 5A) . TMG foci were detected in cells transfected with N86 and FP-SMN, as also in the untransfected cells (Fig. 1I) , indicating that overexpression of fluorescently taggedproteins per se does not affect the composition of CBs. In contrast, a great reduction in the number of transfected cells with TMG foci was observed upon the overexpression of Dex7, DN86 and 472D5 (Pc2£1%). In those cells, the remainder of TMG foci coincided with the FP foci (Fig. 5A) . Overexpression of the Tudor domain, which partially overlapped the nucleoplasmic snRNPs, also depleted snRNPs from CBs. Immunofluorescence experiments using 4G3 monoclonal antibody against the U2 snRNP-specific B" protein confirmed that the number of snRNPs foci was reduced upon expression of these SMN mutants (Fig. 5B ). In addition, mutant Dex7 led to the accumulation of TMG in CB in 30% of transfected HeLa cells (n=942, Pc2£1%) compared to 55% and 60% with FP-SMN transfected (n=579) and untransfected (n=699) cells, respectively. These data indicate that Dex7 leads to reduction of snRNPs in CBs independently of cell type.
To assess the importance of the association of SMN with the snRNP Sm proteins on the localization in CBs, we tested the overexpression of FP-SMNE134K (E134K), a mutant harbouring a glutamic acid to lysine substitution at position 134 in Tudor domain. This mutation, which has been identified in a Type I SMA patient (Clermont et al., 1997) , disrupts the in vitro binding of SMN to the Sm proteins, fibrillarin and GAR1 (Bülher et al., 1999; Whitehead et al., 2002) . The E134K mutant was localized in the cytoplasm and concentrated in an increased number of nuclear foci ( Fig. 5C ; Mohaghegh et al., 1999) . Some of the E134K
foci colocalized with coilin in CBs in 52% of transfected cells and they were gems and CBs in the remainder of cells (Table 1 ). There were as many TMG foci in E134K-transfected cells as in untransfected cells, indicating that the E134K mutant did not affect the localization of snRNP in CBs probably because of its reduced ability to interact with Sm proteins (Buhler et al., 1999) . Taken together with the observations that the other mutants tested depleted the snRNPs from CBs, these results indicate that SMA mutant E134K does not compete for SMN binding sites of snRNPs.
To further assess the role of SMN in the distribution of snRNP in CBs, we investigated the localization of the endogenous SMN in transfected COS cells (Table 1 , Fig. 5D ).
Immunofluorescence analyses of the endogenous SMN was possible with N86, DN86, Tudor and 472D5 using an anti-SMN monoclonal antibody against either the N-terminus of SMN or a bacterially-expressed human SMNDN86 (Burlet et al., 1998) . Endogenous SMN accumulated in nuclear foci of cells transfected with N86, DN86 or Tudor, but no SMN foci were detected in 472D5-transfected cells ( Fig. 5C ; Table 1 ). These results indicate that the reduction of snRNPs in CBs is not associated with the absence of SMN in CBs.
Endogenous SMN protein associates with SMN mutants in transfected cells
Our results indicated that deletion of the C-terminus of SMN in SMND ex7
significantly affects the localization of snRNPs in CBs. To investigate the consequences of ex7 deletion in transfected cells, the FP-SMN and FP-SMNDex7 cell populations were isolated and the levels of endogenous proteins examined. Immunoblot analyses of protein extracts from cells transfected with either construct revealed similar molar ratios of SMN, gemin2, SmB/B' and fusion proteins as compared to tubulin, indicating that there is no massive protein degradation upon transfection (Fig. 6A) . Immunoprecipitation experiments performed using anti-GFP and anti-TMG antibodies showed that both FP-SMN and FPSMNDex7 are associated with endogenous SMN and gemin2 (Fig. 6B) , and with snRNPs ( Fig. 6C-D 
SMA disease affects the distribution of snRNPs in CBs
To determine whether the levels of SMN influence the distribution of snRNPs in CBs, the intranuclear localization of SMN and TMG-capped snRNA of snRNPs was compared in immortalized fibroblasts derived from a control and a SMA Type I individual (Fig.7A ).
Double-labelling experiments showed complete colocalization of SMN and TMG foci in 40%
of control fibroblasts, SMN foci did not accumulate snRNPs in 10% of cells and the remainder 50% of cells were devoid of nuclear foci (n= 953). In immortalized SMA Type I fibroblasts, SMN foci were observed in 6% of cells and these foci did not accumulate TMG (n=870). These results suggest that SMA patients mislocalize snRNPs. To determine whether the intranuclear localization of SMN and snRNPs was correlated with phenotypic severity, we examined the colocalization of SMN and TMG in NBs of sub-confluent primary skin fibroblasts derived from children affected with Type I (severe), Type II (intermediate) and
Type III (moderate) SMA and a control infant (Fig. 7B-C 
Discussion
In this study we have analysed the accumulation of the SMA gene product SMN in the nuclear substructures gems and CBs using a series of fluorescent protein-tagged SMN mutants. Domains governing the nuclear and intranuclear localization of SMN have been identified. Furthermore, newly assembled spliceosomal snRNPs re-entering the nucleus associate with SMN (Narayanan et al., 2004) and transiently move into CBs (Sleeman et al., 2001 ). The role of CBs in snRNP maturation steps (Jàdy et al., 2003; Nesic et al., 2004) and in regeneration of snRNPs after splicing has been described (Pellizzoni et al., 1998; Stanek and Neugebauer, 2004; Schaffert et al., 2004) . To better understand the nuclear roles of SMN, the localization of snRNPs in CBs of cells expressing SMN constructs was investigated. Cells transfected with SMA mutants show severe reduction of snRNPs in CBs whereas snRNPs accumulate in CBs of FP-SMN transfected cells. Moreover, in all three types of SMA-derived fibroblasts the capacity to accumulate snRNPs in CBs is abrogated.
Tudor and self-oligomerization YG-box domains regulate the nucleocytoplasmic distribution of SMN
The SMN Tudor domain is the prototype of a conserved structural motif found in nucleic acid-binding proteins (Selenko et al., 2001; Maurer-Stroh et al., 2003) . This domain mediates interactions with a protein motif formed of RG-rich repeats. Moreover, sDMA residues in the RG-rich C-terminus of snRNP core Sm proteins increases its association to SMN (reviewed in Meister et al., 2002a; Gubitz et al., 2004) . Recent studies have demonstrated that sDMA-containing proteins are localized in the nucleus (Boisvert et al., 2002) and several of these interact with the Tudor domain of SMN (Côté and Richard, 2005) .
Although the Tudor domain does not contain a classical NLS, we now report that it localizes a cytoplasmic protein to the nucleus and enhances the nuclear pool of SMA mutant 472D5 compared to N86 that lacks the Tudor domain. Following the current model, Tudor domaincontaining SMN proteins enter the nucleus bound to snRNP Sm proteins and to factors of the snRNP nucleocytoplasmic trafficking machineries (Buhler et al., 1999; Massenet et al., 2002; Narayanan et al., 2004) . Other examples of proteins co-imported into the nucleus exist, such as the arginine/serine (RS)-rich splicing factors (Cacéres et al., 1997) , the U2 snRNP-specific U2B '' protein (Kambach and Mattaj, 1994) and the splicing factor SF3a (Nesic et al., 2004) .
The role of the Tudor domain in nuclear localization is consistent with the abrogation of in vitro import of SMN after immunodepletion of snRNPs or deletion of the Sm-binding Tudor domain, Dex3 (Narayanan et al., 2004) . Our finding that deletion of the selfoligomerization YG-box (DC40) enhances nuclear localization as compared to Dex7 is somewhat unexpected, since mutations within the YG-box interfere with SMN-binding to Sm proteins (Pellizzoni et al., 1999; Wang and Dreyfuss, 2001 ) and deletion of this domain (Dex6) abrogates SMN import in vitro (Narayanan et al., 2004) . However, nuclear localization of DC40 is consistent with the ability of the Tudor domain to interact in vitro with the general import factor importin-b in the context of Dex6 (Narayanan et al., 2004) . Taken together, these results support the view that Tudor and self-oligomerization YG-box modulate nucleocytoplasmic partitioning of SMN.
Moreover, the finding that removal of the Tudor domain in DN189 does not diminish the nuclear fraction as compared with DN86, suggests that other mechanisms play a role in the nuclear localization of SMN proteins. Indeed, the association of the C-terminus of SMN with the zinc finger protein ZPR1 might regulate nuclear partitioning of SMN (Gangwani et al., 2005) . If SMN can enter the nucleus only with the snRNPs, our results suggest the existence of different pathways for snRNP import, as previously postulated (Fischer et al., 1991) .
Cooperation between domains regulates the localization of SMN in CBs
Our finding that the Tudor domain is essential but not sufficient for the localization of SMN proteins in CBs is somewhat unexpected, since it interacts directly with coilin and Sm proteins that both concentrate in CBs (Carmo-Fonseca et al., 1992) . However, this is consistent with FRET (fluorescence resonance energy transfer) analyses that demonstrated the self-association of SMN in CBs of living cells (Dundr et al., 2004) . Indeed, we find that the C-terminal YG-box stabilizes the localization of SMN in CBs. One explanation for the role of the YG-box in CB localization is that self-oligomerization may enhance SMN accumulation in CBs by promoting binding to CB components, such as snRNPs Pellizzoni et al., 2001; Wang and Dreyfuss, 2001 ). Moreover, we show that the Krich region encoded by ex2B cooperates with the Tudor domain to accumulate SMN mutants in CBs. This domain possibly stabilizes the interaction of the Tudor domain with coilin as suggested by in vitro binding studies (Hebert et al., 2002) . Other examples of proteins that employ different protein motifs for accumulation in CBs are the transcription elongation factor TFIIS (Smith et al., 2003) , the nucleolar protein Nopp140 (Isaac et al., 1998) and the U4/U6 snRNP assembly factor SART3/p110 (Stanèk et al., 2004) . This supports the view that nucleolar and CB components can promote on their own assembly of supramolecular nuclear substructures (Misteli, 2001) . Moreover, proteins that transiently accumulate in dynamic nuclear substructures may serve as molecular scaffold to concentrate nuclear factors (reviewed in Dundr and Misteli, 2001 ).
Additionally, overexpression of SMN mutants lacking at least the C-terminal half of SMN results in nucleolar accumulation of mutants. It has been reported that SMN fractionates with nucleolar proteins in cell cultures (Whitehead et al., 2002) and concentrates in nucleoli of some neuronal cell populations (Francis et al., 1998; Young et al., 2001a) . 
Defects of snRNP localization in CBs correlates with SMA disease
At the cellular level, decrease of SMN levels in SMA is reflected by a decrease in the accumulation of SMN in NBs ( Fig. 6 ; Coovert et al., 1997; Lefebvre et al., 1997; Frugier et al., 2000) . This implies that SMA could have consequences on the localization of snRNP in NBs. Here, we observed that the residual SMN-positive NBs fail to accumulate snRNPs in fibroblasts derived from patients of all three SMA types. This is consistent with the reduction of snRNP assembly in vitro observed using extracts from fibroblast cells of SMA patients (Wan et al., 2005) . In addition, double heterozygous mice deficient in Smn and Gemin2
showed reduced levels of assembled snRNPs (Jablonska et al., 2002 (Narayanan et al., 2004) . Therefore, the complete colocalization of E134K and snRNPs in CBs suggests a more complex association of SMN with snRNPs in the nucleus and leaves open the question how this SMA mutation alters the biogenesis of snRNPs.
Transient expression of the SMN deletion mutants leads to depletion of snRNPs from
CBs similar to what is observed in SMA cells. Although coilin is required for snRNP recruitment in CBs (Tucker et al., 2001; Hebert et al., 2001) , it does not appear sufficient for the accumulation of snRNPs in CBs of cells transfected with our mutants. This is consistent with the idea that coilin does not regulate the dynamics of association with CBs of its components (Platani et al., 2002; Dundr et al., 2004) . Moreover, the reduction of snRNPs in
CBs of cells transfected with SMNDex7, the most frequent SMA mutation, suggests that ex7 region is important for localization of snRNPs in CBs. This is inline with the following observations. Deletion of the SMN C-terminus encoded by ex7 diminishes the oligomerization of SMN (Lorson et al., 1998a) and its binding capacity for the Sm proteins (Pellizzoni et al., 1999; Wang and Dreyfuss, 2001 ) and for TGS1 (Mouaikel et al., 2003) .
Hypermethylation of the snRNA cap structure allows efficient nuclear migration of snRNPs (Mattaj, 1988; Fischer et al., 1991) and in turn, their passage through CBs (reviewed in Cioce and Lamond, 2005) . In light of the presence of some mutants in CBs that are devoid of snRNPs, it is rather SMN that retains snRNPs in CBs than snRNPs that retain SMN proteins in CBs (Carvalho et al., 1999; Sleeman et al., 2001 ).
The exact stoichiometry of the individual components of the SMN complex has not been established (Carissimi et al., 2005) . It is possible that the effects in the distribution of snRNPs in CBs observed as a result of expression of the SMN mutants can be accounted for by altered stoichiometry of the SMN complex. In the co-immunoprecipitation experiments FP-SMN and FP-SMNDex7 associate with endogenous SMN and gemin2 in a distinct stoichiometry. This is in agreement with the idea that truncated SMN might form partially functional SMN complex in a dose-dependent manner. Indeed, truncated proteins rescue cell lethality in avian cell system (Wang and Dreyfuss, 2001 ) and partially restore neuromuscular functions in fruitfly larvae (Chan et al., 2003) and SMA mouse models (Le et al., 2005) . Fulllength SMN might possibly gain functionality within complexes containing the mutants, suggesting that stabilization of SMN complexes could constitute potential therapeutics for SMA.
The typical distribution of coilin in 2 to 8 CBs was observed upon overexpression of FP-SMN, E143K, N86 and DC40 (Fig. 3) . and DN189 did not form nuclear foci and were excluded from CBs. The mutants N86 and ex2B accumulated also in nucleoli (see Fig. S1 ). The microscope was focused on coilinpositive CBs. Inserts show FPs (left), coilin (middle) and merge (right). Scale bars, 3 mm. 
